← Reviews
Aug 3, 2026

Multi-strain probiotic during short-term travel: effects on gut microbiota and systemic symptoms

A five-day Bifidobacterium probiotic regimen during domestic travel altered gut microbiota composition without changing alpha or beta diversity compared to placebo.

Evidence levelBRandomized clinical trial
Study typerct
Sample74
Effect directionFavorable
CertaintyModerate
Clinical applicabilityModerate
Overinterpretation risk1/5 · Low
PICO
Population
Intervention
Comparator
Outcome

What the study showed

The probiotic group showed post-travel enrichment of taxa including Bifidobacterium breve and Lacticaseibacillus species, confirmed by qPCR. Alpha and beta diversity remained stable in both groups, suggesting effects were limited to specific taxonomic composition. Secondary symptom outcomes were recorded but full results are unavailable from the abstract.

How it was done

Randomized, double-blind, placebo-controlled trial in 74 healthy adults traveling to Xinjiang; probiotic arm received B. longum subsp. infantis M-63, B. breve M-16V, and B. longum BB536 at 1.5×10⁹ CFU/day for five days. Gut microbiota was profiled by metagenomic sequencing pre- and post-travel; intention-to-treat analysis.

Risk of bias

The abstract is truncated, precluding access to symptom and KEGG pathway results; five days is insufficient to assess durability of microbiota changes. The sample of 74 participants is modest and the domestic travel context limits generalizability to higher-risk international travel.

Interpretation limit

What this study does NOT prove

The abstract does not prove that the probiotic produced clinically meaningful reductions in gastrointestinal or respiratory symptoms.

In clinical practice

Available data do not support routine clinical recommendation of this probiotic regimen for short-distance travelers. Complete symptom outcome data are needed before any practical guidance.

Limitations

The abstract is truncated, precluding access to symptom and KEGG pathway results; five days is insufficient to assess durability of microbiota changes. The sample of 74 participants is modest and the domestic travel context limits generalizability to higher-risk international travel.

Technical appendix

Version history

  • 1.0 · 2026-08-03 — Auto-generated under Evidence Standard v1.0

Paid access: structured summary from public metadata; consult the original study at the source.

Microbiota Weekly

The week in microbiota evidence, in your language. Structured summaries, traceable to the source.